5062352026-04-012026-06-305062352026-06-305062352026-04-012026-06-30in-capmkt:OtherExpenses1Member5062352026-04-012026-06-30in-capmkt:OtherExpenses2Member5062352026-04-012026-06-30in-capmkt:ReportableSegments1Member5062352026-04-012026-06-30in-capmkt:ReportableSegments2Member5062352026-04-012026-06-30in-capmkt:ReportableSegments1Member5062352026-04-012026-06-30in-capmkt:ReportableSegments2Member5062352026-04-012026-06-30in-capmkt:ReportableSegments1Member5062352026-06-30in-capmkt:ReportableSegments1Member5062352026-04-012026-06-30in-capmkt:ReportableSegments2Member5062352026-06-30in-capmkt:ReportableSegments2Member5062352026-04-012026-06-30in-capmkt:ReportableSegments1Member5062352026-06-30in-capmkt:ReportableSegments1Member5062352026-04-012026-06-30in-capmkt:ReportableSegments2Member5062352026-06-30in-capmkt:ReportableSegments2Member5062352026-04-012026-06-30ItemsThatWillNotBeReclassifiedToProfitAndLoss1iso4217:INRiso4217:INRxbrli:shares506235ALEMBICLTDNOTLISTEDINE426A01027Alembic LimitedMain BoardEquity2026-04-012027-03-312026-08-112026-07-31INRLakhsQuarterlyFirst quarterMulti segment2026-08-1115:30:002026-08-1116:00:00Not applicablefalsefalseNot Applicable2026-04-012026-06-30UnauditedStandalone46265400055504000518158000492860000-5149000104610000374500033815000173480000359787000158371000015837100015943000-4394000115490000146822000000014682200063062400077744600051356400020.570.57000.570.571. The above results have been reviewed by Statutory Auditors, recommended by Audit Committee and approved by the Board of Directors of the Company. <br /> <br /> 2. The previous quarter's / year's figures have been regrouped / rearranged wherever necessary to make it comparable with the current quarter / year. <br /> <br /> 3. The figures for the quarter ended 31st March, 2026 are the balancing figures between the audited figures in respect of full finanacial year ended 31st March, 2026 and year to date unaudited figures upto third quarter ended 31st December, 2025. <br /> <br /> 4.Figures rounded off to the nearest decimal.Cost of Construction86213000Other Expenses87267000Active Pharmaceutical Ingredients Business117130000Real Estate Business3455240004626540000462654000Active Pharmaceutical Ingredients Business16646000Real Estate Business1224450001390910003745000-23025000158371000Active Pharmaceutical Ingredients Business1822827000Real Estate Business51262360006949063000341036100010359424000Active Pharmaceutical Ingredients Business357658000Real Estate Business67071700010283750003390390001367414000Amount of items that will not be reclassified to profit and loss706198000706198000755740000630624000